Daniel Krowarsch

1.9k total citations
51 papers, 1.5k citations indexed

About

Daniel Krowarsch is a scholar working on Molecular Biology, Cell Biology and Biotechnology. According to data from OpenAlex, Daniel Krowarsch has authored 51 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 11 papers in Cell Biology and 11 papers in Biotechnology. Recurrent topics in Daniel Krowarsch's work include Fibroblast Growth Factor Research (18 papers), Enzyme Production and Characterization (11 papers) and Biochemical and Structural Characterization (10 papers). Daniel Krowarsch is often cited by papers focused on Fibroblast Growth Factor Research (18 papers), Enzyme Production and Characterization (11 papers) and Biochemical and Structural Characterization (10 papers). Daniel Krowarsch collaborates with scholars based in Poland, Norway and United States. Daniel Krowarsch's co-authors include Jacek Otlewski, Tomasz Cierpicki, Małgorzata Zakrzewska, Filip Jeleń, Michał Dadlez, Antoni Więdłocha, Olga Buczek, Arne O. Smalås, Jacek Otlewski and Y. Devedjiev and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Molecular Biology and Biochemistry.

In The Last Decade

Daniel Krowarsch

49 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Krowarsch Poland 22 1.0k 239 174 171 167 51 1.5k
Kunchithapadam Swaminathan Singapore 25 1.2k 1.2× 196 0.8× 152 0.9× 317 1.9× 185 1.1× 71 2.2k
Bernhard Schlott Germany 26 1.1k 1.0× 125 0.5× 161 0.9× 118 0.7× 192 1.1× 62 1.7k
Maria A. Kukuruzinska United States 30 1.9k 1.8× 440 1.8× 358 2.1× 170 1.0× 220 1.3× 64 2.5k
Karl‐Heinz Gührs Germany 23 1.2k 1.2× 93 0.4× 204 1.2× 127 0.7× 107 0.6× 45 1.9k
Xianqiang Li China 18 1.0k 1.0× 126 0.5× 142 0.8× 56 0.3× 197 1.2× 48 1.5k
Xue Pei United Kingdom 20 1.0k 1.0× 192 0.8× 110 0.6× 62 0.4× 374 2.2× 31 1.8k
Andrea Scrima Germany 17 1.4k 1.4× 285 1.2× 93 0.5× 60 0.4× 224 1.3× 31 1.8k
Filip Jeleń Poland 13 783 0.8× 183 0.8× 115 0.7× 87 0.5× 73 0.4× 15 1.1k
Didier Busso France 18 1.2k 1.2× 85 0.4× 90 0.5× 86 0.5× 238 1.4× 47 1.5k
Ryohei Ishii Japan 22 1.4k 1.4× 196 0.8× 144 0.8× 42 0.2× 154 0.9× 36 1.8k

Countries citing papers authored by Daniel Krowarsch

Since Specialization
Citations

This map shows the geographic impact of Daniel Krowarsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Krowarsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Krowarsch more than expected).

Fields of papers citing papers by Daniel Krowarsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Krowarsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Krowarsch. The network helps show where Daniel Krowarsch may publish in the future.

Co-authorship network of co-authors of Daniel Krowarsch

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Krowarsch. A scholar is included among the top collaborators of Daniel Krowarsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Krowarsch. Daniel Krowarsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krowarsch, Daniel, et al.. (2025). Production and purification of recombinant long protein isoforms of FGF11 subfamily. Journal of Biotechnology. 403. 9–16. 1 indexed citations
2.
3.
Krowarsch, Daniel, et al.. (2024). Uncovering key steps in FGF12 cellular release reveals a common mechanism for unconventional FGF protein secretion. Cellular and Molecular Life Sciences. 81(1). 356–356. 2 indexed citations
4.
Krowarsch, Daniel, et al.. (2023). Intracellular FGF1 protects cells from apoptosis through direct interaction with p53. Cellular and Molecular Life Sciences. 80(10). 311–311. 1 indexed citations
5.
Krowarsch, Daniel, et al.. (2023). FGF12: biology and function. Differentiation. 139. 100740–100740. 6 indexed citations
6.
Czyrek, Aleksandra, et al.. (2023). FGF homologous factors are secreted from cells to induce FGFR ‐mediated anti‐apoptotic response. The FASEB Journal. 37(7). e23043–e23043. 12 indexed citations
7.
Porębska, Natalia, Aleksandra Czyrek, Daniel Krowarsch, et al.. (2023). Galectins use N-glycans of FGFs to capture growth factors at the cell surface and fine-tune their signaling. Cell Communication and Signaling. 21(1). 122–122. 6 indexed citations
8.
9.
Opaliński, Łukasz, et al.. (2022). FGF12 is a novel component of the nucleolar NOLC1/TCOF1 ribosome biogenesis complex. Cell Communication and Signaling. 20(1). 182–182. 17 indexed citations
10.
Duda, Przemysław, Tomasz Wójtowicz, Daniel Krowarsch, et al.. (2020). Fructose 1,6-Bisphosphatase 2 Plays a Crucial Role in the Induction and Maintenance of Long-Term Potentiation. Cells. 9(6). 1375–1375. 16 indexed citations
11.
Szlachcic, Anna, Aleksandra Czyrek, Łukasz Opaliński, et al.. (2019). Low Stability of Integrin-Binding Deficient Mutant of FGF1 Restricts Its Biological Activity. Cells. 8(8). 899–899. 9 indexed citations
12.
Opaliński, Łukasz, et al.. (2018). High Affinity Promotes Internalization of Engineered Antibodies Targeting FGFR1. International Journal of Molecular Sciences. 19(5). 1435–1435. 28 indexed citations
13.
Krowarsch, Daniel, et al.. (2017). A Conjugate Based on Anti-HER2 Diaffibody and Auristatin E Targets HER2-Positive Cancer Cells. International Journal of Molecular Sciences. 18(2). 401–401. 15 indexed citations
14.
Kobielak, Agnieszka, et al.. (2014). Protease Resistant Variants of FGF1 with Prolonged Biological Activity. Protein and Peptide Letters. 21(5). 434–443. 8 indexed citations
15.
Krowarsch, Daniel, Małgorzata Zakrzewska, Arne O. Smalås, & Jacek Otlewski. (2005). Structure-Function Relationships in Serine Protease-Bovine Pancreatic Trypsin Inhibitor Interaction. Protein and Peptide Letters. 12(5). 403–407. 20 indexed citations
16.
Kowalska, Agnieszka, Iwona Grad, Grzegorz Rymarczyk, et al.. (2004). Plasticity of the Ecdysone Receptor DNA Binding Domain. Molecular Endocrinology. 18(9). 2166–2184. 25 indexed citations
17.
Zakrzewska, Małgorzata, Daniel Krowarsch, Antoni Więdłocha, & Jacek Otlewski. (2004). Design of fully active FGF-1 variants with increased stability. Protein Engineering Design and Selection. 17(8). 603–611. 51 indexed citations
18.
Kim, Myung Hee, Tomasz Cierpicki, Urszula Derewenda, et al.. (2003). The DCX-domain tandems of doublecortin and doublecortin-like kinase. Nature Structural & Molecular Biology. 10(5). 324–333. 108 indexed citations
19.
Buczek, Olga, Daniel Krowarsch, & Jacek Otlewski. (2002). Thermodynamics of single peptide bond cleavage in bovine pancreatic trypsin inhibitor (BPTI). Protein Science. 11(4). 924–932. 22 indexed citations
20.
Helland, Ronny, et al.. (2000). Substitutions at the P 1 ′ position in BPTI strongly affect the association energy with serine proteinases 1 1Edited by R. Huber. Journal of Molecular Biology. 301(1). 205–217. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026